Genomic based risk stratification in prostate cancer screening.

Genomic based risk stratification in prostate cancer screening. - ERSPC 2012/DNA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37676

Enrollment

15000

Registered

2012-11-12

Start date

2013-08-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer Prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Men randomised to the screening arm of ERSPC Rotterdam - Signed informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
SNPs profiling of 110 known SNPs and relate those to the available follow-up data containing information of prostate cancer detection, treatment, progression and casus specific death.	—

Secondary

Measure	Time frame
Assess the possibilities to enhance existing risk stratification tools with genomic based information.	—

Countries

Netherlands

Outcome results